CHARGED ALPHA
Stock Analysis
Stock Library / NVCR
NVCR Unclassified Latest YouTube: Q2 2026 Published 2026-07-25

NVCR

Live stock metrics, chart context, a quarter-by-quarter episode archive, and a deeper competitor comparison so this page behaves more like an investor workspace than a flat episode link page.

Latest earnings video

Novocure Stock: Its First-Ever Profit — and the Stock STILL Round-Tripped. Why We Say SPEC BUY (NVCR Q2 2026)

Published 2026-07-25

Library coverage

Episodes tracked
1
Episodes linked
1
Latest video
Q2 2026
2026-07-25
Podcast available
Yes
Current price
$16.31
-0.73 (-4.28%)
Trailing / Forward P/E
Forward: -20.33x
Market cap / Volume
Volume:
Revenue / Earnings Growth
15.6%
Earnings: —
Margins
-5.8% op
Gross: 76.4% · Net: -21.2%
Balance sheet
2.89x current
Debt / Equity: 69.0
52-week range / Beta
$9.82 - $20.55
Beta: 0.94
Analyst target
$27.14
Upside: 66.4%
Cash / shareholder return
1.21% FCF yield
Dividend yield: —

Company context

Industry: Medical Devices
Country: Switzerland
Employees:
Price to book: 5.71x
Return on equity: -43.2%
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.

Price chart

Market context for NVCR

Competitive view

NVCR vs. two close competitors

This section compares the current company against two nearby peers on valuation, growth, margins, balance-sheet strength, and investment setup. Green generally marks the strongest relative figure for that row, while red marks the weakest.

NVCR latest YouTube video thumbnail YouTube
NVCR
NVCR
Latest video
Q2 2026
Growth is positive but not explosive, which usually supports a steadier compounding case than a hyper-growth story.
Profitability is serviceable, but it does not obviously dominate peers on margin or cash conversion alone.
Valuation looks more grounded than many growth names, which can improve the risk/reward if fundamentals hold up.
Risk profile looks relatively manageable compared with many peers, especially if operating execution remains stable.
SS&C Technologies Holdings Inc. latest YouTube video thumbnail YouTube
SS&C Technologies Holdings Inc.
SSNC
Latest video
Q2 2026
Growth profile looks strong right now, with above-average top-line and/or earnings momentum.
Cash generation stands out versus market value, which helps the stock absorb valuation pressure better than weaker cash converters.
Valuation looks more grounded than many growth names, which can improve the risk/reward if fundamentals hold up.
Balance-sheet leverage is elevated, so investors should watch refinancing costs and how much flexibility management really has.
Danaher Corporation latest YouTube video thumbnail YouTube
Danaher Corporation
DHR
Latest video
Q2 2026
Growth profile looks strong right now, with above-average top-line and/or earnings momentum.
Cash generation stands out versus market value, which helps the stock absorb valuation pressure better than weaker cash converters.
Valuation sits in a middle zone where future upside likely depends more on quarterly execution than on multiple re-rating alone.
Risk profile looks relatively manageable compared with many peers, especially if operating execution remains stable.
Market Cap
More scale can mean deeper resources and resilience, although bigger does not automatically mean better upside.
NVCR
$1.89B
NVCR
SSNC
$18.76B
SS&C Technologies Holdings Inc.
DHR
$139.93B
Danaher Corporation
Trailing P/E
Lower trailing P/E can indicate a cheaper valuation relative to trailing earnings, but it may also reflect slower growth or higher perceived risk.
NVCR
NVCR
SSNC
21.6x
SS&C Technologies Holdings Inc.
DHR
35.1x
Danaher Corporation
Forward P/E
Forward P/E is often a better read on what investors are paying for the next year of earnings power.
NVCR
-20.3x
NVCR
SSNC
10.1x
SS&C Technologies Holdings Inc.
DHR
21.5x
Danaher Corporation
Revenue Growth
Higher revenue growth usually signals stronger demand, market share gains, or a business still in expansion mode.
NVCR
15.6%
NVCR
SSNC
10.3%
SS&C Technologies Holdings Inc.
DHR
5.5%
Danaher Corporation
Earnings Growth
Faster earnings growth matters because it shows management is converting sales momentum into shareholder value.
NVCR
NVCR
SSNC
34.7%
SS&C Technologies Holdings Inc.
DHR
59.7%
Danaher Corporation
Operating Margin
Higher operating margin suggests better operating discipline, pricing power, or a structurally stronger business model.
NVCR
-5.8%
NVCR
SSNC
24.6%
SS&C Technologies Holdings Inc.
DHR
19.8%
Danaher Corporation
Gross Margin
Gross margin helps show how much product-level pricing power and unit economics a company has before overhead.
NVCR
76.4%
NVCR
SSNC
48.1%
SS&C Technologies Holdings Inc.
DHR
58.8%
Danaher Corporation
Net Margin
Higher net margin means more of each dollar of revenue reaches the bottom line after all costs.
NVCR
-21.2%
NVCR
SSNC
13.2%
SS&C Technologies Holdings Inc.
DHR
15.9%
Danaher Corporation
Return on Equity
ROE shows how efficiently management turns shareholder capital into profits, though leverage can inflate it.
NVCR
-43.2%
NVCR
SSNC
12.6%
SS&C Technologies Holdings Inc.
DHR
7.6%
Danaher Corporation
Free Cash Flow Yield
Higher free cash flow yield can indicate a stronger cash return relative to the stock's market value.
NVCR
1.2%
NVCR
SSNC
6.9%
SS&C Technologies Holdings Inc.
DHR
3.1%
Danaher Corporation
Debt to Equity
Lower leverage usually means less balance-sheet risk, though capital-intensive sectors naturally run higher debt loads.
NVCR
69.04x
NVCR
SSNC
115.90x
SS&C Technologies Holdings Inc.
DHR
52.97x
Danaher Corporation
Current Ratio
A stronger current ratio usually signals better short-term liquidity and more room to absorb shocks.
NVCR
2.89x
NVCR
SSNC
1.06x
SS&C Technologies Holdings Inc.
DHR
1.65x
Danaher Corporation
Beta
Lower beta often means lower volatility versus the market, while higher beta usually brings a rougher ride.
NVCR
0.94
NVCR
SSNC
1.11
SS&C Technologies Holdings Inc.
DHR
0.82
Danaher Corporation
Dividend Yield
Dividend yield matters for income-focused investors, but a high yield can also reflect a stressed stock price.
NVCR
NVCR
SSNC
0.7%
SS&C Technologies Holdings Inc.
DHR
0.7%
Danaher Corporation
Analyst Upside
Higher analyst upside suggests the Street still sees room between current price and consensus fair value.
NVCR
66.4%
NVCR
SSNC
18.5%
SS&C Technologies Holdings Inc.
DHR
14.3%
Danaher Corporation

Related research

Non-quarter videos featuring NVCR

Special-topic videos, explainers, and shorts connected to this ticker.

All Research Sections
Shorts and Clips 2026-07-25

Novocure (NVCR): First-Ever Profit — But We Say SPEC BUY #stocks #investing #NVCR

A fast Charged Alpha clip pointing viewers into the latest earnings coverage.

Episode timeline

Episode archive for NVCR

Each row is one earnings episode with every verified platform link available.

Q2 2026
Episode live
2026-07-25
Published youtube podcast complete
Novocure Stock: Its First-Ever Profit — and the Stock STILL Round-Tripped. Why We Say SPEC BUY (NVCR Q2 2026)
Quarterly earnings-analysis entry for NVCR. Use the links on the right to open the video or podcast episode.